Skip to main content

  • Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis

    • Posted: 10/01/2021
    • Author:

      Jose M. de la Torre Hernández, Raymundo Ocaranza Sanchez, Melisa Santas Alvarez, Eduardo Pinar Bermudez, Jose A. Hurtado Martinez, Bruno Garcia del Blanco, Imanol Otaegui, Eduard Fernandez Nofrerias, Xavier Carrillo Suarez, Fermin Sainz Laso, Juan M. Casanova Sandoval, Pedro K. Rivera Aguilar, Belen Cid, Ramiro Trillo, Fernando Lozano Ruiz-Poveda, Vicente Peral Disdier, Miren Telleria, Alfonso Torres, Juan Sanchis, Xavier Oliva, Xavier Freixa, Mario Sadaba Sagredo, Jose Moreu and Felipe Hernández

    • 2021CRM

    Abstract

    Objectives

    We sought to evaluate clinical outcomes in patients treated with the drug-eluting stent ihtDEStiny BD.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details